Burcon NutraScience Corp (BUR) vs. Its Peers Head to Head Comparison
Burcon NutraScience Corp (NASDAQ: BUR) is one of 196 publicly-traded companies in the “Biotechnology & Medical Research” industry, but how does it compare to its rivals? We will compare Burcon NutraScience Corp to related companies based on the strength of its profitability, earnings, analyst recommendations, valuation, dividends, risk and institutional ownership.
This table compares Burcon NutraScience Corp and its rivals’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Burcon NutraScience Corp||-2,884.35%||-162.68%||-92.88%|
|Burcon NutraScience Corp Competitors||-3,991.19%||-119.33%||-44.09%|
This is a summary of recent ratings for Burcon NutraScience Corp and its rivals, as reported by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Burcon NutraScience Corp||0||0||0||0||N/A|
|Burcon NutraScience Corp Competitors||790||2961||6466||145||2.58|
As a group, “Biotechnology & Medical Research” companies have a potential upside of 5.17%. Given Burcon NutraScience Corp’s rivals higher probable upside, analysts clearly believe Burcon NutraScience Corp has less favorable growth aspects than its rivals.
Institutional and Insider Ownership
1.4% of Burcon NutraScience Corp shares are owned by institutional investors. Comparatively, 48.9% of shares of all “Biotechnology & Medical Research” companies are owned by institutional investors. 14.0% of shares of all “Biotechnology & Medical Research” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Risk and Volatility
Burcon NutraScience Corp has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, Burcon NutraScience Corp’s rivals have a beta of 1.63, meaning that their average share price is 63% more volatile than the S&P 500.
Earnings and Valuation
This table compares Burcon NutraScience Corp and its rivals revenue, earnings per share and valuation.
|Gross Revenue||EBITDA||Price/Earnings Ratio|
|Burcon NutraScience Corp||$64,663.00||-$4.55 million||-5.59|
|Burcon NutraScience Corp Competitors||$207.80 million||-$2.19 million||-0.33|
Burcon NutraScience Corp’s rivals have higher revenue and earnings than Burcon NutraScience Corp. Burcon NutraScience Corp is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Burcon NutraScience Corp rivals beat Burcon NutraScience Corp on 8 of the 9 factors compared.
Burcon NutraScience Corp Company Profile
Burcon NutraScience Corp (Burcon) is a Canada-based company, which is engaged in development of functional and renewable plant proteins. The Company has developed a portfolio of composition, application and process patents originating from a core protein extraction and purification technology. The Company and its subsidiary have developed CLARISOY, a soy protein; and are developing Peazazz, a pea protein, and Puratein, Supertein and Nutratein, approximately three canola protein isolates. The Company’s products are targeted at the protein ingredient market and are particularly suited to health and wellness applications. The CLARISOY portfolio includes CLARISOY 100, 110, 120 and 150 for low potential of Hydrogen (pH) applications, and CLARISOY 170 and 180 for neutral applications. Peazazz is well-suited for use in low pH and neutral pH beverages, dairy alternative products, meal replacements, as well as a range of other healthy food and beverage product applications.
Receive News & Stock Ratings for Burcon NutraScience Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Burcon NutraScience Corp and related stocks with our FREE daily email newsletter.